Depomed, Inc. (DEPO) Thursday said it acquired all rights to Zipsor liquid filled capsules from Xanodyne Pharmaceuticals, Inc., in return for $25.9 million of cash and potential milestone payments based on sales of Zipsor and assumption of certain liabilities.
Zipsor is a non-steroidal anti-inflammatory drug, known to relieve mild to moderate acute pain in adults.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.